文献速递心胸血管麻醉疼痛医学

心脏手术加速康复计划中阿片类药物节约策略的二次分析

Opioid-Sparing Cardiac Anesthesia: Secondary Analysis of an Enhanced Recovery Program for Cardiac Surgery.
PubMed 文献 · Anesth Analg · 2020-01-01

该研究为心脏手术加速康复计划(ERP)数据的二次分析,纳入451例连续患者,评估5项非阿片干预与术中阿片用量的关联。每增加一项干预,术中阿片用量估计减少7.96 MSE(95%CI -9.82至-6.10,P<.001)。低阿片组(≤50 MSE)与高阿片组(>50 MSE)倾向匹配后术后并发症、疼痛评分、拔管时间和住院时间无差异;超低阿片组(≤25 MSE)与高阿片组比较亦无差异。

要点

  • 心脏手术ERP中非阿片干预数量与术中阿片用量呈负相关。
  • 低阿片与超低阿片用量未显著增加术后并发症或延长住院。
  • 结果属假设生成性,需前瞻性研究验证阿片节约策略的作用。

核心结论

  • 心脏手术ERP中采用的非阿片干预与术中阿片用量减少相关。
  • 低阿片和超低阿片用量与术后结局无显著差异。

研究设计与样本

  • 研究为某机构心脏手术ERP数据的回顾性二次分析,共纳入451例连续患者。
  • 所有患者接受5项非阿片干预:术前加巴喷丁和对乙酰氨基酚、术中右美托咪定和氯胺酮输注、前锯肌平面阻滞区域镇痛。
  • 主要目标通过线性混合效应回归模型评估术中阿片用量与干预数量的关联。
  • 术后结局比较采用倾向匹配:低阿片组(≤50 MSE,n=136)与高阿片组(>50 MSE,n=136)1:1匹配,基于15个患者和手术协变量。
  • 超低阿片组(≤25 MSE,n=63)与高阿片组(n=132)按1:3倾向匹配后比较。

主要发现

  • 术中阿片用量与干预数量呈负相关,每增加一项干预估计减少7.96 MSE(95%CI -9.82至-6.10,P<.001)。
  • 低阿片组与高阿片组在术后并发症、术后疼痛评分、拔管时间或住院时间方面未检测到差异。
  • 超低阿片组与高阿片组在结局方面未发现差异。

关键数值与推荐

  • 标准患者阿片用量为70至105 morphine sulfate equivalents(MSE;芬太尼10-15 µg/kg)。
  • 低阿片定义为>50 MSE为高阿片,≤50 MSE为低阿片;超低阿片定义为≤25 MSE。
  • 5项非阿片干预包括术前加巴喷丁和对乙酰氨基酚、术中右美托咪定和氯胺酮输注、前锯肌平面阻滞。

临床怎么用

  • 心脏手术ERP中可考虑联合使用非阿片干预以减少术中阿片用量。
  • 低至超低阿片用量未显示与术后结局恶化相关,但需前瞻性研究确认。

局限性

  • 研究为回顾性二次分析,结果属假设生成性。
  • 需未来前瞻性研究确立阿片节约策略在心脏手术中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiac anesthetics rely heavily on opioids, with the standard patient receiving between 70 and 105 morphine sulfate equivalents (MSE; 10-15 µg/kg of fentanyl). A central tenet of Enhanced Recovery Programs (ERP) is the use of multimodal analgesia. This study was performed to assess the association between nonopioid interventions employed as part of an ERP for cardiac surgery and intraoperative opioid administration. METHODS: This study represents a post hoc secondary analysis of data obtained from an institutional ERP for cardiac surgery. Consecutive patients undergoing cardiac surgery received 5 nonopioid interventions, including preoperative gabapentin and acetaminophen, intraoperative dexmedetomidine and ketamine infusions, and regional analgesia via serratus anterior plane block. The primary objective, the association between intraoperative opioid administration and the number of interventions provided, was assessed via a linear mixed-effects regression model. To assess the association between intraoperative opioid administration and postoperative outcomes, patients were stratified into high (>50 MSE) and low (≤50 MSE) opioids, 1:1 propensity matched based on 15 patients and procedure covariables and assessed for associations with postoperative outcomes of interest. To investigate the impact of further opioid restriction, ultralow (≤25 MSE) opioid participants were then identified, 1:3 propensity matched to high opioid patients, and similarly compared. RESULTS: A total of 451 patients were included in the overall analysis. Analysis of the primary objective revealed that intraoperative opioid administration was inversely related to the number of interventions employed (estimated -7.96 MSE per intervention, 95% confidence interval [CI], -9.82 to -6.10, P < .001). No differences were detected between low (n = 136) and high (n = 136) opioid patients in postoperative complications, postoperative pain scores, time to extubation, or length of stay. No differences were found in outcomes between ultralow (n = 63) and high (n = 132) opioid participants. CONCLUSIONS: Nonopioid interventions employed as part of an ERP for cardiac surgery were associated with a reduction of intraoperative opioid administration. Low and ultralow opioid use was not associated with significant differences in postoperative outcomes. These findings are hypothesis-generating, and future prospective studies are necessary to establish the role of opioid-sparing strategies in the setting of cardiac surgery.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Grant MC, Isada T, Ruzankin P, et al. Opioid-Sparing Cardiac Anesthesia: Secondary Analysis of an Enhanced Recovery Program for Cardiac Surgery. Anesth Analg. 2020. PMID: 32889848. doi:10.1213/ANE.0000000000005152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。